Last quarter (Q3 2023), Unity Biotechnology's total revenue was $976.00K, an increase of Infinity% from the same quarter last year. In Q3, Unity Biotechnology's net income was $-15.29M. See Unity Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 1.86M	$ 236.00K	$ 4.78M	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 1.86M	$ 236.00K	$ 4.78M	-	-	-
Operating Expense	$ 23.63M	$ 57.81M	$ 61.45M	$ 91.33M	$ 91.00M	$ 74.92M
Operating Income	$ -51.46M	$ -57.57M	$ -56.66M	$ -91.33M	$ -91.00M	$ -74.92M
Net Non Operating Interest Income Expense	$ -288.00K	$ -2.34M	$ -3.08M	$ -96.00K	$ 3.29M	$ 3.31M
Other Income Expense	$ 6.38M	$ 17.00K	$ 983.00K	$ -2.41M	$ 5.54M	$ -4.79M
Pretax Income	$ -52.53M	$ -59.93M	$ -60.73M	$ -93.84M	$ -82.18M	$ -76.40M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -52.53M	$ -59.93M	$ -60.73M	$ -93.84M	$ -82.18M	$ -76.40M
Basic EPS	$ -7.42	$ -6.31	$ 0.00	$ -1.84	$ -1.88	$ -2.70
Diluted EPS	$ -7.14	$ -6.31	$ -10.90	$ -1.84	$ -1.88	$ -2.70
Basic Average Shares	$ 52.83M	$ 9.49M	$ 5.58M	$ 50.86M	$ 43.62M	$ 28.27M
Diluted Average Shares	$ 52.83M	$ 9.49M	$ 5.58M	$ 50.86M	$ 43.62M	$ 28.27M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 23.63M	$ 57.81M	$ 61.45M	$ 91.33M	$ 91.00M	$ 74.92M
Net Income From Continuing And Discontinued Operation	$ -52.53M	$ -59.93M	$ -60.73M	$ -93.84M	$ -82.18M	$ -76.40M
Normalized Income	$ -876.31K	$ -47.34M	-	$ -91.25M	$ -83.53M	$ -71.86M
Interest Expense	-	-	-	$ 1.29M	$ 0.00	$ 0.00
EBIT	$ -49.89M	$ -56.37M	$ -57.55M	$ -92.55M	$ -82.18M	$ -76.40M
EBITDA	$ -49.13M	$ -53.15M	$ -52.81M	$ -89.10M	$ -79.51M	$ -74.22M

Currency in USD

Unity Biotechnology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing